Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. NHS medicines information on alendronic acid – what it's used for, side effects, dosage and who can take it.

  2. Only a few randomized controlled trials investigating antiosteoporotic agents with fracture endpoints have included participants over the age of 80 years. The pivotal trial with alendronic acid had an upper age range of 80 years, although a separate ...

  3. Patient Forums for Alendronic Acid. Part of the Bones, joints and muscles category. Symptom, treatment and advice from community members.

  4. Table 1: High Risk Patients. Age ≥75 years. 1st Choice : Alendronic acid 70 mg weekly (oral)2nd Choice: Risedronate 35 mg weekly (oral). Recommended in those who are intolerant of alendronate or have active oesophageal reflux symptoms.

  5. Alendronate*, risedronate*, zoledronic acid, denosumab and teriparatide† are licensed for the treatment of osteoporosis in men. Alendronate and risedronate should be the first line treatments in the majority of cases. *Only alendronate 10mg daily tablet and risedronate 35mg weekly tablet are licensed for use in men.

  6. 18 mar 2004 · We report the results of a multinational randomized, double-blind study, in which postmenopausal women with osteoporosis were treated with alendronate for up to 10 years.

  7. 23 lis 2021 · Bisphosphonates are the mainstay in therapeutic option for the prevention and treatment of osteoporosis (1). alendronate and etidronate are licensed for the treatment of corticosteroid-induced osteoporosis in men (3).

  1. Ludzie szukają również